Literature DB >> 2569622

Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine.

C C Harland, E M Saihan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569622     DOI: 10.1016/s0140-6736(89)90619-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Topical diphencyprone as an effective treatment for cutaneous metastatic melanoma.

Authors:  Young Jin Kim
Journal:  Ann Dermatol       Date:  2012-07-25       Impact factor: 1.444

Review 2.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

3.  Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data.

Authors:  Ali Khosravi; B Jayaram; Bahram Goliaei; Ali Masoudi-Nejad
Journal:  Mol Med       Date:  2019-06-20       Impact factor: 6.354

4.  Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience.

Authors:  Ivana Lameiras Gibbons; Marina Sonagli; Eduardo Bertolli; Mariana Petaccia de Macedo; Clovis Antonio Lopes Pinto; João Pedreira Duprat Neto
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

5.  Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy.

Authors:  Sophia Haywood; Jennifer Garioch; Arjun Ramaiya; Marc Moncrieff
Journal:  Ann Surg Oncol       Date:  2020-06-15       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.